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Key Points
· Organizational advocacy capacity is an increas-
ingly important area of inquiry, raising questions 
about the opportunities (and limits) for achieving 
and sustaining policy change.  
· The California Endowment implemented the 
Clinic Consortia Policy and Advocacy Program to 
expand grantee advocacy capacity to support the 
policy and operational needs of California’s com-
munity clinics.
· In-person meetings with decision-makers and 
developing working relationships were among 
the key advocacy activities undertaken by 19 
grantees. Grantees secured several policy wins 
through a variety of strategies, including mobilizing 
member clinics to be potent advocates.  
· The “return on investment analysis” indicates that 
grantees secured policymaker support for clinic 
programs and services that brought member clin-
ics a total of $1.63 billion from 2001 to 2009 to 
increase access to care. 
· Longer-term outcomes achieved by grantee policy 
and program initiatives included a strengthened 
health care safety net and increased access to 
health care for medically underserved Californians. 
· Funders of advocacy and policy change initia-
tives are encouraged to consider the resources 
needed to build and sustain advocacy capacity, 
including grantee technical expertise, partnerships 
with stakeholders, and time required to expand 
advocacy capacity.
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Introduction 
Private foundations are increasingly willing to 
fund individuals and organizations to advocate 
for policy changes that benefit vulnerable popula-
tions. For example, The California Endowment, 
the Annie E. Casey Foundation, the Atlantic 
Philanthropies, and the W.K. Kellogg Founda-
tion provide grant support to help organizations 
advocate for policies that increase access to health 
care and improve food systems. They also provide 
funding to advocates to create lasting change in 
their communities through activities including 
community organizing, targeted issue advocacy, 
and outreach campaigns (Harvard Family Re-
search Project, 2007). 
As part of its commitment to increasing access 
to high-quality, affordable health care for under-
served Californians, The California Endowment 
provided nine years of funding for the Clinic 
Consortia Policy and Advocacy Program. In 2001, 
15 California local and regional community clinic 
associations and four statewide clinic organiza-
tions received $10 million in funding over three 
years to strengthen their capacity to support the 
policy and operational needs of community clin-
ics. In 2004 and 2007, The Endowment renewed 
funding, granting $18 million over three years to 
18 grantees to start or continue similar activities.1 
Clinic consortia are nonprofit statewide, regional, 
and local associations of primary-care clinics that 
1 One grantee was not funded in 2004 and 2007, bringing 
the total number of grantees to 18.
undertake activities that individual clinics may 
not be able to do on their own (See Table 1.) 
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In addition to providing funding, The California 
Endowment developed individual and cross-
grantee objectives for each round of funding. 
It used a six-month interim-report template 
and final-report template to monitor individual 
grantee progress. The Endowment was also a key 
evaluation partner, assisting in the development 
of evaluation measures, identifying key areas 
for further inquiry, and co-hosting the annual 
evaluation convenings. It was also important to 
The Endowment that grantees learned from one 
another. The annual convenings and case stud-
ies provided grantees with lessons learned and 
gave them an opportunity to discuss their work 
and its implications. Last, a significant number 
of foundation staff were involved throughout the 
nine-year period to learn how the program could 
serve as a model for other multisite, multilevel 
policy initiatives and advocacy investments. 
The evaluation began in 2002 and collected data 
for the entire grant period of 2001 through 2009. 
It focused on how The California Endowment’s 
grant supported grantees in responding to the 
challenges of the shifting health care and politi-
cal environments, such as budget shortfalls and 
changes to the Medicaid program.2
California is unique in having upwards of 18 
community clinic consortia; the oldest consor-
tium, the California Rural Indian Health Board 
(CRIHB), was launched in 1969. Five grantees 
were launched in the 1970s and two grantees 
were launched in the 1980s. Ten grantees were 
launched in the early 1990s to help clinics transi-
tion to Medicaid managed care. 
Consortia vary in size and membership, staff-
ing, scope of services, geographic focus, and 
age. Clinic needs vary; smaller, rural clinics need 
different types of support compared to large, mul-
tisite corporations. Although clinic consortia are 
diverse in their membership focus and areas of 
expertise, they all help individual clinics meet the 
needs of their patient populations. They provide a 
unified voice calling for increased services to the 
uninsured, offer economies of scale for business 
2 Additional analyses from the evaluation can be found at 
http://ihps.medschool.ucsf.edu/News/california_ 
endowment.aspx
TABLE 1  
Grantees or Clinic Consortia
Alameda Health Consortium (AHC)
Alliance for Rural Community Health (ARCH)
California Family Health Council (CFHC)
California Planned Parenthood Education Fund (CPPEF)
California Primary Care Association (CPCA)
California Rural Indian Health Board (CRIHB)
Capitol Community Health Network (CCHN)
Central Valley Health Network (CVHN)
Coalition of Orange County Community Clinics (COCCC)
Community Clinic Association of Los Angeles County (CCALAC)
Community Clinic Consortium Serving Contra Costa and Solano Counties (3C)
Community Health Partnership, Inc. (CHP)
Council of Community Clinics (CCC)
North Coast Clinics Network (NCCN)
Northern Sierra Rural Health Network (NSRHN)
Redwood Community Health Coalition (RCHC)
San Francisco Community Clinic Consortium (SFCCC)
Shasta Consortium of Community Health Centers (SCCHC)
Expanding Organizational Advocacy Capacity
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and program shared services, and allow clinics to 
work in partnership on local health improvement 
programs to benefit clients. 
Collectively and individually, the grantees used 
this funding to educate policymakers and target 
clinic policy issues, establishing themselves as a 
voice at the federal, state, and county levels for 
the 951 primary-care clinics in California that 
serve 4.8 million low-income and uninsured Cali-
fornians (Office of Statewide Health Planning and 
Development, 2009).3 Program funding supported 
advocacy activities to sustain needed health care 
services for vulnerable populations, including 
convening forums, publishing educational materi-
als, conducting media advocacy, and providing 
advocacy technical assistance to increase the col-
lective influence of clinics.4
Background
Collective political action by groups of all types 
is an important means for inclusion of voices 
that otherwise might be silent in U.S. politics and 
policymaking (Richardson, 1993; Baumgartner 
& Leech, 1998). These groups are referred to by 
many names, including political groups, special 
interest groups, and voluntary associations, and 
there is a large body of work detailing their spe-
cific tactics. For example, Schlozman and Tierney 
(1986) found that 14 of the 27 influential activities 
that were employed by advocacy organizations 
were used by 80 percent or more of the groups 
surveyed, ranging from testifying at hearings to 
grassroots lobbying efforts. In their review of six 
surveys of interest groups activities, Baumgartner 
and Leech (1998) had similar findings – namely, 
that although groups tend not to specialize and 
employ a particular strategy, they are often strate-
gic in their deployment of specific tactics. A more 
recent study found that advocates use particular 
strategies based on available resources, the lob-
bying target, the particular policy issue, and the 
legislative context (Victor, 2007). 
Additionally, the universe of advocacy activi-
3 These 951 primary-care clinics are not all members of the 
18 consortia grantees.
4 Please note that lobbying activities were not funded under 
this program and are assumed to be funded by other fund-
ing sources.
ties and groups has expanded due in large part 
to greater government involvement in new and 
existing areas, including the health care arena 
– which experienced a sizeable increase in the 
number of interest groups during the early 1990s 
when national health care reform efforts mobi-
lized stakeholders from all sectors (Wiessert & 
Wiessert, 1996). Within the Medicaid program, 
for example, is a plethora of interests represented 
by influential groups, including providers, the 
elderly, people with disabilities, children in low-
income families, and low-income adults (Krone-
busch, 1997). 
It is exceedingly difficult, however, to assess the 
actual influence of these groups on policymaking, 
such as decision-maker support for a specific pol-
icy. There is evidence that interest groups strive to 
be influential – e.g., political action committees 
make large financial contributions to members of 
Congress – but their actual effectiveness varies 
greatly (Baumgartner & Leech, 1998). Addition-
ally, some advocacy tactics may be more influen-
tial than others. For example, Kelleher and Yackee 
(2006) found that interest groups that spent time 
with bureaucrats were more likely to influence 
state-agency rulemaking than those that did not. 
Collecting, analyzing, and disseminating informa-
tion on key policy issues may be more important 
than other advocacy activities to secure access to 
It is exceedingly difficult to assess 
the actual influence of these groups 
on policymaking, such as decision-
maker support for a specific policy.  
There is evidence that interest 
groups strive to be influential – e.g., 
political action committees make 
large financial contributions to 
members of Congress – but their 
actual effectiveness varies greatly.
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decision makers (Kersh, 2007; Salisbury, Johnson, 
Heinz, Laumann, & Nelson, 1989). Advocacy 
success also may be highly contingent on specific 
conditions, such as restrictions on lobbying (Low-
ery & Gray, 2004). However, the recent develop-
ment of advocacy-capacity and decision-maker 
support evaluation measures is expanding our 
ability to identify and assess advocacy strategies 
and account for contextual factors.5
 Evaluation Methodology
In 2002, the University of California, San Fran-
cisco (UCSF) evaluation team began a multiyear 
evaluation to assess the outcomes and effec-
tiveness of The California Endowment’s Clinic 
Consortia Policy and Advocacy Program. As 
described in the “program logic model” developed 
by The Endowment (see Table 2), the program is 
based on the theory that staffing and resources 
dedicated to policy advocacy and technical as-
sistance will increase the collective influence of 
clinics and strengthen a broad base for long-term 
support of clinic policy issues. These activities 
are anticipated to contribute to improved health 
outcomes for target communities. The model 
provided the basis for identifying indicators and 
measures for the external evaluation, as well as 
for monitoring individual grantee progress in 
achieving their respective outcomes.
5 The California Endowment, the Alliance for Justice and 
others have developed or compiled research and evaluation 
measures for use by researchers, advocates, and funders.
UCSF used a three-part approach to create a 
learning, participatory process whereby the evalu-
ation findings met the needs of all stakeholders: 
1. Creation of a mixed-method evaluation tool-
kit that combined rigor with reflection. UCSF 
used an outcomes framework to assess the 
program outcomes and qualitative methods 
to characterize grantee and program accom-
plishments. 
2. Provision of evaluation technical assistance or 
creating a learning environment to strengthen 
grantee evaluation activities. During the first 
two rounds of the grant (2001-2006), UCSF 
worked with grantees to develop and use 
individual logic models and to communicate 
evaluation findings. 
3. Communications or creating an information 
feedback loop. An important feature of the 
design was sharing evaluation results with 
grantees and the funder through hosting 
annual grantee meetings in which evalua-
tion results were reviewed, and developing 
useful documents that could be shared more 
broadly. These efforts were used as a quality-
improvement loop and assisted grantees in 
their planning efforts.
Assessing group influence can greatly benefit 
from the use of policy-change stage models that 
describe the policymaking process. Such mod-
TABLE 2  
Program Logic Model
Increased grantee advocacy capacity 

Increased policymaker awareness 
of safety-net and clinic policy issues
 
Increased policymaker support 
for clinic funding
 
Strengthened clinic operations
 
Increased services for the underserved 
and uninsured
 
Improved health outcomes 
for targeted communities and populations
Expanding Organizational Advocacy Capacity
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els include clear points where advocates can 
intervene before, during, and after the legisla-
tive process. In the UCSF evaluation design, we 
worked with a modified stage model to organize 
the nonlobbying activities undertaken by grantees 
that were profiled in the three evaluation policy 
case studies (See Table 3.) 
Data Collection Methods
Because the evaluation began during the first 
round of funding (2001-2003), UCSF used a com-
bination of quantitative longitudinal measures; 
stakeholder, media and policymaker surveys; and 
qualitative case studies to both capture the early 
experience with the program and monitor prog-
ress6 (See Table 4.) As the evaluation progressed, 
we replaced interim measure, such as the Advo-
cacy Activities Worksheet, with other approaches 
to assess the longer-term outcomes, such as case 
studies, as well as deepen our inquiry in the areas 
of partnerships and media coverage. A few ap-
proaches, specifically the Funding Secured Work-
sheet and Annual Grantee Interviews, spanned 
the entire grant period of 2001 through 2009.
To assess the role of the grant in increasing 
grantee capacity in policy advocacy, the first 
program outcome, a collection of quantitative 
and qualitative tools were administered. First, the 
6 We are not including all of the evaluation-data collec-
tion activities in this article; specifically, our assessment 
of grantee media advocacy activities and partnership activi-
ties are reported elsewhere.
Advocacy Activities Worksheet assessed grant-
funded policy-advocacy activities from 2002 to 
2006, including the level (federal, state, local) at 
which they targeted these activities, the perceived 
effectiveness of these activities, and whether these 
activities contributed to three desired annual 
objectives: increased clinic funding, increased 
policymaker awareness, and achieved a policy 
change.7 Second, Annual Grantee Interviews doc-
umented their progress since the previous year 
and contextual information, such as facilitating 
factors and barriers to success. Third, the Imple-
mentation and Sustainability Survey assessed the 
initial impact of Round 1 of the program (2001-
2003) on grantee capacity to engage in advocacy 
and plans for sustainability.  
To assess the role of the grant in increasing deci-
sion-maker familiarity with consortia, clinic ac-
tivities, and clinic policy issues, the Policymaker 
and Community Leaders Awareness Survey was 
completed by 86 policymakers and community 
leaders well-known to consortia in 2003. In 2004, 
the Stakeholder Awareness Survey was completed 
by 43 state and local policymakers and commu-
nity leaders whom grantees perceived to be less 
familiar with consortia but who were nonetheless 
considered important stakeholders in California’s 
health care safety net. 
7 The number of advocacy activities increased by one or 
two activities annually during the course of the grant, for 
a total of 16 activity types.  However, in the longitudinal 
analysis, we assessed a subset of these activities (13) and 
grantees (15) that remained the same from 2002 to 2006.
TABLE 3  
Stages of Policymaking Process and Potential Advocacy Activities
Stage 1. Policy-issue recognition: Advocacy efforts are focused on educating and encouraging appointed and 
elected officials to recognize the compelling nature of the policy issue, increasing their motivation to act (e.g., policy 
forums, in-person meetings, media advocacy).
Stage 2. Agenda setting: Determining which issues will occupy the attention of decision-makers (e.g., securing 
media coverage, influencing public opinion).
Stage 3. Policy prioritization: The policy issue is formally adopted and key decision-makers actively advocate 
on its behalf in order to achieve the remaining stages (e.g., providing information on policy impacts on target 
populations). 
Stage 4. Policy implementation: Legislative action, new legislation, and/or protocols are implemented (e.g., 
working with agencies to draft rules and regulations).
Stage 5. Policy maintenance: Advocates, interest groups, politicians, and other stakeholders work to sustain 
public interest and attention, with hopes for ongoing support of the implemented policies (e.g., partnerships with 
advocacy allies, educating new policymakers). 
(Theodoulou, 1995; Lowery & Brasher, 2004)
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Year Data Collection Activity Focus
2003 Grantee Interviews (n=19) Changes in activities and relationship with media 
Advocacy Activities Worksheet 
(n=15)
Effectiveness of advocacy activities 
Policymaker and Community 
Leader Awareness Survey (n=86 
leaders targeted through program 
activities) 
Perceptions of consortia advocacy activities
2004 Grantee Interviews (n=18) Changes in activities and relationship with media
Advocacy Activities Worksheet 
(n=15)
Effectiveness of advocacy activities
Funding Secured Worksheet 
(n=18)
Funding secured by grantees that can be attributed to 
grant
Grantee Implementation and 
Sustainability Survey (n=19)
Advocacy-capacity gains and resources required to 
support these activities
Clinic Focus Groups (n=11) Perceptions of consortia advocacy activities and benefits
Stakeholder Awareness Survey 
(n=43 leaders less familiar with 
consortia)
Perceptions of consortia advocacy activities
Policies Outcome Worksheet 
(n=17)
Federal, state, and local policies targeted by grantees
2005 Grantee Interviews (n=17) Changes in activities and relationship with media
Advocacy Activities Worksheet 
(n=15)
Effectiveness of advocacy activities
Funding Secured Worksheet 
(n=15)
Funding secured by grantees that can be attributed to 
grant
Policies Outcome Worksheet 
(n=17)
Federal, state, and local policies targeted by grantees
2006 Grantee Interviews (n=18) Changes in activities and relationship with media
Advocacy Activities Worksheet
 (n=15)
Effectiveness of media advocacy activities
Funding Secured Worksheet 
(n=18)
Funding secured by grantees that can be attributed to 
grant
Policies Outcome Worksheet 
(n=18)
Federal, state, and local policies targeted by grantees
Clinic Focus Groups (n=9) Perceptions of consortia advocacy activities and impacts 
on clinics and their communities
Policy Advocacy Case Studies (3) 3 policies targeted by a subset of grantees
2007 
-2010
Grantee Interviews (n=18) Changes in activities and relationship with media
Funding Secured Worksheet 
(n=18)
Funding secured by grantees that can be attributed to 
grant
Policies Outcomes Worksheet 
(n=18)
Federal, state, and local policies targeted by grantees
2009 
-2010
Individual Grantee Case Studies 
(n = 16)
Detailed case studies of 16 policy and program initiatives 
undertaken during the grant period (2001-2009) that 
demonstrated achievement of the program longer-term 
outcomes
TABLE 4   Evaluation Data Collection Instruments, 2001-2010
Expanding Organizational Advocacy Capacity
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To assess success in increasing policymaker 
support for clinic funding, a Policies Worksheet 
was completed by grantees from 2004 to 2009 
detailing information on their targeted federal, 
state, and local policies as well as the objectives 
achieved, including passage of legislation and 
funding secured. Second, a Funding Secured 
Worksheet provided information on the sources 
and amount of funding secured by all grantees 
on behalf of clinics and consortia from 2001 to 
2009 that could be attributed to program-funded 
activities, as well as the allocation of these funds 
to clinics and consortia. 
To assess the impact of grantee advocacy and 
policy change on strengthened clinic opera-
tions, UCSF conducted two Focus Groups of 11 
and nine clinic executive directors in 2004 and 
2006, respectively. UCSF asked participants to 
identify clinic capacity gains supported under 
the grant, as well as perceived benefits of grantee 
policy advocacy to clinics and their communi-
ties. Clinic staff were also interviewed for the 17 
Individual Grantee Case Studies described below, 
and were asked to describe the impact of a policy 
or program on clinic operations and services and 
patient utilization of clinic services. 
UCSF assessed the latter two outcomes, increased 
services for the underserved and uninsured and 
improved health outcomes for targeted commu-
nities and populations, by developing Policy Case 
Studies in 2006 and 2007 focusing on three suc-
cessful policies at the state and local levels aimed 
at securing funding to integrate mental health 
and primary care services under the state Mental 
Health Services Act (Proposition 63), successful 
implementation of the state Medi-Cal Prospective 
Payment System, and passage and implementa-
tion of Measure A in Alameda County. UCSF also 
developed 17 Individual Grantee Case Studies of 
policy or program initiatives that demonstrated 
achievement of one or both outcomes, e.g., quan-
titative data on increased enrollment in Medi-Cal, 
the state’s Medicaid program. UCSF conducted 
open-ended interviews in 2009-10 with grantee 
staff, decision makers, clinic staff, and partner or-
ganizations that were involved with the initiative. 
Informants were asked to describe their level of 
involvement, the stakeholders involved, challeng-
es encountered, and benefits to clinics and their 
target populations. Informants were also asked to 
provide quantitative evidence of achievement for 
program outcomes, such as the number of unin-
sured Californians enrolled in public or private 
insurance or in coordinated services. 
Analyses 
All the qualitative and quantitative data were 
entered into Microsoft Office Excel to organize 
and analyze the data. Quantitative data, par-
ticularly the effectiveness data – such as grantee 
perception of usefulness of media advocacy 
– were tabulated in Filemaker Pro, a relational 
database software program. Qualitative data were 
categorized, coded, and tabulated to identify 
the most frequently mentioned responses. Since 
legislation can be pending for up to two years, 
UCSF clustered federal and state bills targeted by 
grantees by the three rounds of funding. Because 
the grantee population is small, in some cases we 
present the number of grantees that provided a 
specific response rather than the percentage. To 
strengthen the trend analysis of the Advocacy 
Activities Worksheet data, we adjusted all the 
years and eliminated the activities and grantees 
that did not stay constant for the five-year period. 
Additionally, the funding secured by grantees 
on behalf of clinics and consortia that could be 
attributed to grant-funded activities was deter-
mined by using a percentage estimate of grantee 
staffing devoted to activities funded under the 
grant. UCSF provided a metric that grantees used 
to calculate their percentage of involvement. 
Actual funding secured – federal, state, local, and 
private – was calculated using this metric. Input 
from the focus groups was transcribed and ana-
lyzed for common themes and benefits to clinics. 
Last, the Policy Case Studies were analyzed for 
crosscutting strategies and factors for success.
Findings
From 2001 to 2009, grantees used Endowment 
resources to develop their internal capacity (e.g., 
hiring an experienced policy director, learning 
how to secure media coverage) to undertake 
diverse advocacy activities at the federal, state, 
and local levels. Overall, the findings suggest 
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these capacity gains resulted in tangible benefits 
to clinics and their target populations, such as the 
strengthening of California’s health care safety 
net and improved health status of key clinic target 
populations. In this section, we report the find-
ings by program outcome. 
Outcome 1: Increased Grantee Capacity in 
Policy Advocacy 
Overall, there was an annual increase in advocacy 
activities undertaken by grantees, from 120 activi-
ties in 2002 (72.7 percent of surveyed activities) to 
142 activities in 2006 (86.1 percent). Local grant-
ees experienced a modest increase in their activi-
ties, while statewide and regional grantees stayed 
relatively constant. Grantee involvement – the 
percentage of grantees that undertook a specific 
activity “more,” “less,” or “same” – stayed constant 
for most activities from 2002 to 2006. The level 
of focus of these advocacy activities – federal, 
state, or local – did not vary that much, either. 
(See Figure 1). However, grantees increased their 
involvement in activities specific to the policy-
making process, particularly “helping draft rules, 
regulations, and guidelines” and “consulting with 
elected officials to plan policymaking strategies.” 
(See Figure 2).
We identified the key advocacy capacity gains that 
grantees might not have been able to do without 
the first round of program funding (2001-2003): 
1. increased capacity to monitor the policy envi-
ronment (89 percent); 
2. increased advocacy technical assistance to 
clinics (84 percent); 
3. provision of written briefs and other materials 
to others, e.g., “action alerts” (79 percent); 
4. increased staffing (74 percent); and 
5. expanded level of focus, e.g., county and state 
policy arenas (68 percent). 
Interestingly, the grantee perceptions of the 
success of their advocacy activities in achiev-
ing the desired outcomes stayed fairly constant 
from 2002 to 2006 and ranged from 3.28 to 3.36, 
where 4 equaled “very effective” (N=15 grantees). 
“Helping draft rules, regulations and guidelines” 
experienced the greatest increase in effective-
ness since 2002 (from 3.14 to 3.50). Two activities 
decreased in perceived effectiveness from 2002 
to 2006: “media advocacy” (from 3.31 to 2.57) 
and “engaging in informal contacts with elected 
officials about general points of view” (from 3.58 
to 3.00). 
FIGURE 1  Number of Grantee Advocacy Activities, by Level of Membership Focus, 2002-2006
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Figure 1: Number of Grantee Advocacy Activities, by Level of Membership Focus, 
2002-2006
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From 2002 through 2006, there were modest 
differences in advocacy activities by grantee age 
(pre-1990 and post-1990). By 2006, younger and 
older grantees engaged in the same percentage of 
activities (86 percent). However, older grantees 
were significantly more active at the federal level 
(70 percent vs. 49 percent) from 2002 to 2006. 
Additionally, early in the grant period, younger 
grantees were less likely to perceive their advoca-
cy activities as achieving key program objectives. 
By 2006, however, there were limited differences 
in the perceptions of effectiveness of activities, 
with all consortia similarly perceiving their activi-
ties as resulting in “increased funding to clinics,” 
and "achieving a policy change.” 
The analysis of three types of policies that re-
sulted in financial gains to clinics – state Prospec-
tive Payment System (PPS) for Medi-Cal (SB 36), 
Measure A in Alameda County, and local Mental 
Health Services Act (Proposition 63) funding in 
two counties – afforded a detailed look at how 
grantee advocacy resulted in these policy “wins.” 
The impact of PPS on clinics was significant, 
securing a more beneficial payment methodology 
for clinic Medi-Cal services. Measure A provided 
new funding (approximately $16.8 million over 
three years) to community clinics and strength-
ened the county’s safety net. The local Mental 
Health Services Act (MHSA) provided $1 mil-
lion a year for three years to clinics in Alameda 
County for integrated mental health and primary 
care programs, and $5.6 million over two and a 
half years for San Diego County. Key factors that 
contributed to grantee success included “staff ex-
pertise and long-time relationships,” the ability to 
“participate early and often during the planning 
and implementation phases,” “business acumen” 
and “the ability to make financial projections,” the 
“ability to build coalitions and mobilize stakehold-
ers,” and the “ability to leverage partnerships with 
member clinics.” For example, grantees facilitated 
partnerships among stakeholders early on and 
then applied their technical expertise in alloca-
tion methodologies (e.g., collecting and analyzing 
clinic financial and utilization data) later on in the 
implementation stage. 
While consortia used similar advocacy strategies, 
there were some differences. For example, the 
media was used extensively in Alameda County to 
increase policymaker and community awareness 
about the role of clinics, while the media played 
less of a role in implementation of PPS and secur-
ing of local MHSA funding. PPS negotiations also 
included discussions with federal, state, and local 
decision-makers, while Measure A and MHSA 
funding were primarily local decisions.
Outcome 2: Increased Policymaker Awareness 
of Safety Net and Clinic Policy Issues
Grantees reported that nearly all advocacy 
activities consistently increased policymaker 
awareness. (See Figure 3). These perceptions 
were corroborated by our findings from surveys 
of two different cohorts of decision-makers. The 
FIGURE 2  Grantee Involvement in Individual Advocacy Activities: 2002-2006 
Figure 2: Grantee Involvement in Individual Policy Advocacy Activities: 2002-2006  
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policymakers surveyed in 2003 were well known 
to consortia and reported high familiarity with 
clinic consortia (3.7 where 4 equaled “very famil-
iar”), consortia activities (3.3), and clinic policy 
issues (3.6). They also felt that “consortia-spon-
sored policy events” (74 percent) and “consortia 
media activities” (60 percent) were “very effec-
tive.” Finally, 90 percent rated consortia as “very 
effective” in “meeting the needs of the uninsured.” 
In 2004, we surveyed state and local policymak-
ers and community leaders whom grantees per-
ceived to be less familiar with consortia or clinics, 
but who were nonetheless considered important 
stakeholders in California’s health care safety net. 
These stakeholders reported less familiarity with 
clinic consortia (2.7 where 4 equaled “very famil-
iar”), but high familiarity with consortia activities 
(3.5), and clinic policy issues (3.4). A somewhat 
smaller percentage of the 2004 stakeholders than 
of the 2003 policymakers felt that “consortia-
sponsored policy events” (61 percent) and “con-
sortia media activities” (42 percent) were “very 
effective.” Finally, 71 percent of the stakeholders 
rated consortia as “very effective” in “meeting the 
needs of the uninsured.”
Outcome 3: Increased Policymaker Support for 
Clinic Funding
UCSF tabulation of state and federal legislation 
targeted by grantees indicates that grantees ex-
perienced an increase in federal legislation (from 
5 to 10 bills) that was signed in to law, signaling 
a change in administration and new funding 
opportunities. Passage of state legislation stayed 
somewhat constant (20 to 26 bills), despite an 
increasingly negative environment for policies 
requesting new funding. (See Figure 4.) In addi-
tion, grantees focused on existing programs like 
Family PACT, an 1115 Medicaid waiver focused 
on reproductive-health coverage, to expand 
the number of clients served. Last, policies that 
created cost-savings were emphasized, e.g., the 
Provider Enrollment Streamlining (AB 2307) 
legislation, which streamlines the enrollment of 
primary-care clinics as providers in California’s 
various public programs, thereby eliminating 
costly duplicative requirements. 
The financial gains from many of these poli-
cies were significant. In total, grantees reported 
securing more than $5.27 billion between 2001 
and 2009, with $1.63 billion (31 percent) of 
that financing attributable to support from The 
California Endowment.8 Total funding secured by 
grantees that was attributable to their advocacy 
and fund-development activities increased from 
$104 million in 2001 to $364 million in 2009. (See 
Figure 5.) Most of these funds (about 90 percent 
annually) were directed to clinics and the remain-
der went to consortia. Much of this funding (64 
8 By “attributable to support from The California Endow-
ment,” we mean that program funding paid for staff time 
that was used to secure this funding. The remaining 70 
percent of funding secured by grantees was supported 
by other means, such as core-support grants from other 
foundations, lobbying or other organizations that played 
a lead role in securing the funding that was not supported 
by this grant.
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percent) was maintained funding (versus new 
funding), such as clinic Medi-Cal funding. 
Upon closer examination, the change in funding 
over time by source of funding reveals a changing 
policy environment, with varying funding levels 
by source. Local funding increased throughout 
the grant period, becoming the largest source 
of funding (36 percent), due in large part to 
county contracts for clinics. Federal funding was 
stable and was the second-largest public funding 
source (34 percent), particularly clinic funding 
directed to Federally Qualified Health Centers 
and funding under the American Recovery and 
Reinvestment Act of 2009. State funding was the 
third-largest source (25 percent) and experienced 
a significant decline in 2009 due to the elimina-
tion of Medi-Cal optional benefits (such as adult 
dental) and Traditional Clinic Programs, such as 
the state-funded Expanded Access to Primary 
Care program. Private funding, such as founda-
tion support, remained stable (5 percent) during 
the grant period. 
Additionally, the 17 individual grantee case 
studies illustrate the linkages between grantee 
education activities that contribute to increased 
policymaker awareness of the role of community 
clinics and support for policies or programs that 
increase access to care for clinic target popula-
FIGURE 5  Total Funds Attributed to Endowment Policy and Advocacy Program Activities 
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tions. Most grantees (13) were able to secure 
some form of monetary support from either lo-
cal, state, or federal decision-makers. Seven were 
successful at either maintaining existing fund-
ing or receiving new funding, e.g., for expanded 
Medi-Cal provider reimbursement rates. Four 
grantees secured county contracts for member 
clinics and two grantees received county in-kind 
support, such as staff time, office space, or train-
ing. Policymaker support can also be nonmon-
etary; four grantees received letters of support 
for their policy position or help in convening 
stakeholders. (See Table 5.)
Outcome 4: Strengthened Clinic Operations
The evaluation findings demonstrate a variety 
of areas in which the grant strengthened clinic 
operations. First, most of the funds secured by 
grantees – 90 percent – were directed to clinics 
and their target populations, including funding 
for patient services, clinic facilities, technical as-
sistance, and programmatic expansions, such as 
information technology. The 2004 and 2006 clinic 
focus group participants also described funding 
gains that consortia had helped them achieve, 
such as mobilizing clinics to apply for clinic 330 
and 330 look-alike status to secure federal fund-
ing.
Second, the focus group participants said that 
consortia had increased their representation in a 
variety of state and local policy initiatives, such 
as securing local contracts. Clinics have come to 
rely on the consortia, indicating that it is ex-
tremely helpful to have someone whose job it is 
to digest information, analyze the impact of up-
coming legislation, develop strategies, and engage 
clinic staff, and sometimes patients/consumers, 
in policy advocacy. There was overwhelming 
consensus among focus group participants that 
consortia had increased the ability of clinics to 
influence policy. As one participant put it: “We 
are a force to be reckoned with.”
Additionally, clinic focus group participants said 
consortia had strengthened their institutional 
relationships and helped to forge new partner-
ships, such as with the county health department. 
They also reported that consortia brought new 
resources and expanded the provision of ser-
vices, such as introducing clinics to new infor-
mation technology systems. Grantee and clinic 
informants provided anecdotal information on 
expanded clinic operations, including outreach 
and enrollment, e.g., co-locating a certified appli-
cation assister for on-site public health insurance 
enrollment; increased coordination of services, 
e.g., adoption of the medical home model; and 
expanded advocacy skills, e.g., patients trained by 
a clinic consortia to advocate for clinic policies. 
They also described benefits of these areas of ex-
pertise to the clinic, particularly expanded capac-
ity to serve new patients, expanded reimburse-
ment for uninsured patients, and reconfiguring of 
TABLE 5  Funding Secured by Individual Grantees (Partial List), by Level
Federal funding secured:
•	 Title X funding for reproductive health services was increased by 3% in 2008 and 2009 (CFHC).
•	 Tribal Health Programs received a 13% increase in funding in the 2010 HIS budget (CRIHB).
State funding secured:
•	 SB 94 was passed, for an increase in Medi-Cal provider reimbursement rates for family-planning services 
(CPPEF).
• $40 million was allocated to 146 community clinics under the Community Clinic Grant Program of 2005 (CPCA).
County funding secured:
•	 Four clinics will receive $2.3 million in MHSA funding in Alameda County (AHC).
•	 Mendocino Board of Supervisors provided $240,000 in general fund support for Healthy Kids Mendocino 
(ARCH).
•	 Los Angeles County expanded the Public Private Partnership Program by $46 million in 2010, benefiting 18 
clinics (CCALAC).
•	 Contra Costa County paid 45 clinics $1.5 million to provide services to upwards of 5,000 uninsured 
undocumented immigrants (3C).
•	 San Diego County awarded the Council of Community Clinics $1.8 million for 3 years to administer MHSA 
funding for 9 clinics (CCC).
Expanding Organizational Advocacy Capacity
2011 Vol 3:1&2 35
clinic services to better meet the needs of target 
populations, e.g., co-location of mental health and 
primary care services. 
Outcome 5: Increased Services for the 
Underserved and Uninsured
Of the 17 grantee initiatives, seven grantee policy 
or program initiatives resulted in expanded clinic 
services and consequently an increase in utiliza-
tion of services. For example, one grantee secured 
$46 million in new funding for 18 community 
clinics in Los Angeles County that will be used 
to expand services for an additional 401,163 
encounters. Additionally, two grantees reported 
expanded enrollment in insurance for children, as 
well as an increase in well-child prevention visits. 
In Sonoma County, approximately 9,000 children 
were enrolled in public and private insurance 
through a public-private partnership between the 
county health agency and a grantee from 2005 
to 2009. In many cases, advocacy continues to 
be an important component to achieve program 
sustainability, protecting clinics from regula-
tory challenges as well as sustaining policymaker 
support. For example, one grantee is constantly 
monitoring potential changes in Health Profes-
sional Shortage Area regulations and engaging 
decision-makers to write letters of support when 
clinic interests are at risk. (See Table 6 for a list of 
specific initiatives and the number of actual and 
anticipated patient visits.) 
Outcome 6: Improved Health Outcomes for 
Targeted Communities and Populations
While the most challenging outcome to assess, 
a “strengthened health care safety net” that bet-
ter meets the needs of the community was seen 
in seven grantee initiatives. Of the 17 grantee 
initiatives, four grantee initiatives were able to 
strengthen the relationship between clinics and 
their patients through adoption of the patient-
centered medical homes, and two grantees 
increased availability of mental health services in 
the clinic setting. Second, five initiatives demon-
strated “improved health status for clinic target 
populations,” such as the reduction of unintended 
teen pregnancies. Last, a couple of initiatives 
demonstrated other communitywide outcomes, 
such as increased use of preventive services by 
newly insured children and decreased use of 
emergency room services. Decision-makers and 
partner organizations spoke positively of these 
countywide or system wide changes and the 
benefits to the community, including the preser-
vation of clinic services in the face of state and 
local budget cuts, the increasingly important role 
of clinics in providing care for the uninsured, and 
the linking of people to the right place for care.9
Program Lessons for Funders
Clinic consortia were found to be an effective 
9 The 17 four-page individual case studies can be found at 
http://ihps.medschool.ucsf.edu/News/california_ 
endowment.aspx
TABLE 6  Evidence of Achievement of Longer-Term Program Outcomes
Increased insurance coverage: 
•	 The number of uninsured children in Mendocino County was reduced from 16% to 8% from 2005 to 2007.
•	 Certified Application Assistors in Sonoma County processed more than 83,0000 applications since 1998 (25,000 
per year). About 9,000 children were enrolled in public and private insurance in Sonoma County from 2005 to 
2009.
Increased utilization of clinic services:
•	 There has been an increase of 70,000 clinic clients since the Medi-Cal provider reimbursement rate increase 
went into effect.
•	 It is estimated that the $40 million in clinic infrastructure funding under The Community Clinic Grant resulted in 
700,000 visits.
•	 The $46 million in new funding for community clinics in Los Angeles County will provide an additional 401,163 
encounters.
•	 5,000 undocumented immigrants retained access to primary-care services in Contra Costa County.
•	 Securing HPSA designations resulted in 36,655 patient visits in rural Northern California.
•	 The number of Medi-Cal clients served by community clinics in Orange County increased from 8% to 17%.
•	 Community clinics in San Francisco serve as the medical home for 21,982 Healthy San Francisco participants 
(43%). 
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voice for change on behalf of their member 
clinics, and their accomplishments in the policy 
realm have strengthened clinic operations as well 
as expanded clinic services of all types. The evalu-
ation findings suggest that nearly all grantees 
made significant progress in achieving the first 
five program outcomes, resulting in a strength-
ened health care safety net and access to care 
for millions of Californians. In this section, we 
discuss the relevance of the findings for expand-
ing advocacy capacity, including suggestions for 
parlaying these capacity gains into meaningful 
and lasting change. 
Increased Capacity to Become an Effective 
Voice for Change 
Our longitudinal research is one of the few efforts 
to document annual changes in advocacy group 
capacity and how long it takes to become an ef-
fective voice. The comparison among consortia 
that were formed before and after 1990 suggest 
advocacy-capacity gains take two or three years to 
secure. The capacity gains by younger grantees in-
dicate the advocacy funding allowed them to hire 
an experienced advocate, as well as free up staff 
time to focus on advocacy, played an important 
role in quickly leveling the field among new and 
old grantee organizations. Newer agencies, for 
example, can hire an experienced advocate as well 
as free up staff time to focus on advocacy. 
Once resources were mobilized, grantees expand-
ed their repertoire of advocacy activities from 
2002 to 2006 in number, type, and in the effort 
devoted to these activities. Grantees were able 
to respond to opportunities at multiple levels, 
monitor emerging issues in diverse policy arenas, 
and apprise a broad target audience of key issues 
and their repercussions. For example, grantees 
expanded their venues and strategies for ap-
proaching, educating, and working with decision-
makers, ranging from participation on commit-
tees during the early planning stages of policies to 
shaping rules and regulations post-passage at the 
local and state levels. 
Staffing or hiring of a part- or full-time policy 
director may be the key factor here. Similar to 
an interest group entrepreneur, these individuals 
are responsible for collecting and disseminating 
information, monitoring and targeting key policy 
issues, acting as agents for the membership, and 
communicating with the media, public and public 
officials (Ainsworth, 2002). Grantee policy direc-
tors play an important role in strengthening the 
relationships among member clinics, as well as 
creating a policy agenda that reflects those of the 
membership. 
Strategic Involvement in the Policymaking 
Process
Although earlier research has shown that some 
advocacy activities may be more effective then 
others, our data suggest the differences are mod-
est. Except media advocacy, which declined in 
perceived effectiveness to 2.57, the difference 
between the highest- and lowest-rated activ-
ity rarely exceeded 0.5. Interestingly, the most 
effective activity varied somewhat from 2002 to 
2006, with “helping to draft rules and regula-
tions” being perceived as an increasingly effec-
tive strategy to pursue. This activity was also 
considered the most effective in “achieving a 
policy change” and “increased funding to clinics,” 
two program objectives. These findings suggest 
The comparison among consortia 
that were formed before and after 
1990 suggest advocacy-capacity 
gains take two or three years to 
secure. The capacity gains by 
younger grantees indicate the 
advocacy funding allowed them to 
hire an experienced advocate, as 
well as free up staff time to focus on 
advocacy, played an important role 
in quickly leveling the field among 
new and old grantee organizations.
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grantees have leveraged their capacity gains and 
secured entrée into key policy arenas, where they 
can parlay their technical expertise. Moreover, 
these findings speak to the importance of being 
involved throughout the policymaking process as 
described in our stage model, and not focusing 
on only one or two stages. As described earlier, 
the policy-change stage model demonstrates 
the importance of engaging in different types 
of activities at numerous points in the process. 
Policy change is complex and thus, as Lowery and 
Brasher (2004) point out, advocacy activities must 
be used strategically and tailored to different stag-
es of the process. However, ongoing participation 
in the decision-making process raises important 
questions about deploying limited resources and 
sustaining advocacy expertise over an extended 
period of time. 
Gaining Access to and Establishing Partnerships 
With Decision-Makers 
The findings on high policymaker and stakeholder 
awareness of consortia, the safety net, and clinic 
policy issues early on in the grant period (2003-
04) speak to grantee success in targeting and edu-
cating decision-makers on important clinic issues, 
such as the increase in the number of uninsured. 
To those policymakers already familiar with 
clinic consortia, grantees are viewed as credible 
partners to whom policymakers can turn to for 
information and input on policy issues, creating 
the basis for an ongoing relationship. High poli-
cymaker familiarity with consortia activities and 
perceived high effectiveness with consortia media 
events were shown to bode well for influencing 
the clinic policy agenda. 
The moderately high level of familiarity among 
stakeholders less known to consortia suggests 
grantees have made inroads in developing rela-
tionships beyond their usual allies. Since Califor-
nia has term limits, grantees are under increased 
pressure to maintain their relationship-building 
efforts, as well as broaden their efforts beyond the 
decision-makers who focus on their particular 
policy issues, such as Medicaid, as there is con-
stant churning of decision-makers. 
 
Moreover, the depth and breadth of these rela-
tionships may be critical to advocacy success. As 
the grant progressed, grantees spoke increasingly 
of the importance of in-person meetings and 
establishing ongoing working relationships with 
decision-makers, such as participation on com-
mittees and work groups that include a represen-
tative from the county board of supervisors and 
regular presentations to decision-makers on the 
clinic role in addressing the health care needs of 
the uninsured. The grantee perceptions of the 
importance of the quality and frequency of their 
interactions with decision-makers are supported 
by the findings by Kelleher and Yackee (2006) that 
informal interactions are important to the policy 
outcome.
The most effective activity varied 
somewhat from 2002 to 2006, 
with “helping to draft rules and 
regulations” being perceived as 
an increasingly effective strategy 
to pursue.  This activity was also 
considered the most effective in 
“achieving a policy change” and 
“increased funding to clinics,” two 
program objectives.  These findings 
suggest grantees have leveraged their 
capacity gains and secured entrée 
into key policy arenas, where they 
can parlay their technical expertise. 
Moreover, these findings speak to 
the importance of being involved 
throughout the policymaking 
process.
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 Achieving a Policy Change: Gains to Member 
Clinics and Their Target Populations
The increase in the number of federal and state 
policies targeted by grantees from 2001 to 2006 
reflects the sustained capacity to influence 
decision-making in the face of increasingly lim-
ited opportunities for new funding. The findings 
from the policy case studies show how grantees 
successfully targeted policies that provide new 
funding, such as state and local tobacco settle-
ment funds or county-level measures to fund the 
safety net. Grantees included a variety of policy-
relevant strategies within their portfolio that 
they were able to apply to different and emerging 
policy issues, including pursuing passage of local 
measures, developing a coordinated approach to 
state-level policy change among multiple grant-
ees, and partnering with county agencies to se-
cure a local policy change. Clearly, being mindful 
to the policy context is important to determining 
how to deploy limited resources and determine a 
successful strategy (Victor, 2007).
 The funding secured by grantees speaks to their 
versatility and willingness to target traditional and 
new funding streams, as well as leverage a mix of 
advocacy tactics. We can also use these findings 
to tell a more robust story of the policy environ-
ment at the federal, state, and local levels. When 
we analyze individual funding streams, a detailed 
picture of the differences among federal, state, 
local, and private funding emerges, as well as the 
role played by particular policies. Federal and lo-
cal funding were important for compensating for 
the periodic shortfalls at the state level. Federal 
funding was fairly consistent from 2001 to 2009, 
reflecting bipartisan support for clinic services 
under both political administrations. Local fund-
ing, particularly county contracts for clinic ser-
vices, increased during the grant period. In sum, 
grantee efforts are increasingly pitted against 
larger negative macro forces, such as the grow-
ing number of uninsured being served by clinics. 
Opportunities at the federal and local level have 
helped, but they do not necessarily provide an 
adequate safety net for all of California’s com-
munity clinics. Opportunities within health care 
reform, including substantial funding for safety 
net providers, will require an even greater level 
of political astuteness by clinics and consortia to 
assure that they can continue to increase access 
to care for the newly insured and remaining unin-
sured populations, 
Partnering With Clinics to Expand Political 
Reach and Strengthen Clinic Operations
The findings from the 2004 and 2006 clinic focus 
groups suggest member clinics have come to see 
clinic consortia as advocacy allies and important 
voices working on their behalf in the policy and 
political arenas. In addition, the evaluation noted 
that clinic executive directors are potent political 
voices in their own right. Collaboration between 
consortia and member clinics on key policy is-
sues is important for developing sound policy 
solutions and implementation guidelines. The 
literature on the benefits afforded to members 
by groups is extensive, such as social material 
gains and supporting a specific mission or agenda 
(Baumgartner & Leech, 1998). However, there 
are few studies that examine the ways in which 
advocates can mobilize their membership beyond 
grassroots advocacy. Our findings speak to an 
important synergy between member clinics and 
consortia staff that increases the likelihood of 
creating a workable solution for all concerned, as 
well as expanding the recognition of the “clinic 
voice,” which traditionally has served to give voice 
to those clients whose voices are rarely heard in 
policymaker circles. 
Grantee efforts are increasingly 
pitted against larger negative macro 
forces, such as the growing number 
of uninsured being served by clinics.  
Opportunities at the federal and 
local level have helped, but they do 
not necessarily provide an adequate 
safety net for all of California’s 
community clinics.
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Evaluating Advocacy Capacity and Policy 
Change: Approaches and Challenges
Considered a difficult-to-measure, “messy” area of 
inquiry, the evaluation of advocacy groups, their 
activities, and the outcomes of their campaigns 
pose many challenges (Coates & Rosalind, 2002). 
First, it is difficult to attribute a specific advocacy 
activity to a particular policy outcome, and less 
obvious activities may be more important in de-
termining a policy outcome. Additionally, a policy 
change may produce outcomes well beyond the 
evaluation period. Advocacy evaluators are thus 
striving to focus on interim activities earlier in the 
policy process, such as developing relationships 
with decision-makers, strengthening advocacy 
alliances with other advocates, and developing 
internal expertise to work with the media. 
Initially, the scope of the evaluation posed many 
challenges. While the design focused primarily on 
grantee achievements in the aggregate, grantees 
varied in membership, date of incorporation, size, 
and target populations, creating differences in 
advocacy capacity, such as limited advocacy allies 
in a policy arena. Second, we began the evalu-
ation in the second year of the program (2002) 
and did not have baseline or pre-program data 
against which to compare subsequent changes. 
There were also some differences in program 
policy goals and individual grantee objectives by 
round. For example, grantees were asked to focus 
on cultivating partnerships with traditional allies 
in the health arena (e.g., clinics, other consortia) 
during Round 1. During Rounds 2 and 3, they 
were encouraged to expand their partnerships 
more broadly to nonhealth stakeholders, such as 
the business community. Additionally, we had to 
contend with a lack of existing evaluation models 
and measures to use in an evaluation of advocacy 
efforts, i.e., assessing the impact of a particular 
advocacy activity on a particular piece of legisla-
tion. Next, the long time horizon and resources 
required to measure some advocacy activities, 
such as the effectiveness of media advocacy in 
changing public awareness of the role of clinics, 
precluded ready assessment. Last, grantees were 
limited to engaging in nonlobbying activities 
under the program, such as educating decision-
makers on issues more generally. Consequently, 
we were unable to assess and compare the full 
compliment of advocacy tactics deployed at dif-
ferent stages of the policymaking process.
 
However, we were able to address nearly all of 
these issues and gain insights into evaluation 
strategies that might be useful in other situations. 
First, grantees had similar policy objectives dur-
ing each round that lent themselves to develop-
ment of cross-grantee, longitudinal measures, 
such as assessment of specific advocacy activities 
directed to a particular policy. Some measures, 
specifically funding secured and targeted policies, 
could be measured across all three rounds. Sec-
ond, survey instruments developed by political 
scientists to characterize interest groups and their 
activities served as a good foundation for the de-
velopment of new questionnaires and assessment 
tools. Annual adjustment of the evaluation frame-
work allowed for necessary flexibility to focus 
on prioritized learning objectives, for example, 
sustainability efforts during an economic down-
turn. Triangulation of the findings from different 
data collection activities was critical to address-
ing methodological issues of bias and sampling, 
strengthening the findings. Third, the program’s 
long time horizon turned out to be very useful for 
assessing other advocacy capacity gains and their 
impacts, particularly the monitoring and analysis 
Another challenge was addressing 
the different information needs of 
the evaluation stakeholders. We 
learned that advocates themselves 
benefited more from detailed 
descriptions of particular policies 
and factors for success (or failure), 
while funders often looked for 
broader-stroke findings to guide 
future programmatic investments.
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of specific policy changes and their outcomes. We 
were also able to identify quick-to-assess interim 
or process measures, such as developing relation-
ships with the media and annual content analysis 
of print coverage, where the time horizon was less 
of an issue. Last, while we were unable to assess 
and compare specific lobbying strategies, such as 
in-person meetings to present a position on a bill 
or measure, we addressed this issue in a couple 
of ways: 1) we conducted an analysis of legisla-
tion and local decisions since they are a useful 
indicator of capacity, while acknowledging that 
lobbying probably did play a role, although it was 
paid for by different sources of funding, and 2) we 
identified all the nonlobbying advocacy activities 
funded under the program, such as grantee media 
advocacy targeting broader health issues and 
convening annual policy forums to educate local 
decision-makers. 
Another challenge was addressing the different 
information needs of the evaluation stakeholders. 
We learned that advocates themselves benefited 
more from detailed descriptions of particular 
policies and factors for success (or failure), while 
funders often looked for broader-stroke findings 
to guide future programmatic investments. On 
the other hand, the longitudinal measures on ad-
vocacy activities proved to be very helpful to the 
funder and the UCSF evaluation team in identify-
ing potential areas for increased support, such 
as working with the media. The latter strategy 
provided legitimacy to the clinic voices and was 
a useful conduit for getting the clinic’s messages 
to a far broader audience. We also developed dif-
ferent types of evaluation documents to address 
the different information needs of the funder and 
grantees, such as the development of two-page, 
accessible “best practices” case studies that could 
be readily disseminated by grantees to a broad 
target audience. 
Lessons Learned
Our findings indicate grantees supported by the 
Clinic Consortia Policy and Advocacy Program 
have experienced notable achievements at all 
stages of the program logic model. First, they sig-
nificantly expanded their advocacy capacity and 
repertoire of activities, using these skills to secure 
a place at the policy table. Once there, they were 
successful in increasing policymaker awareness 
and navigating difficult policy terrains, such as 
negotiating complex clinic reimbursement rates 
and maintaining Medi-Cal funding during state 
budget shortfalls. Next, they leveraged policy-
maker support and partnerships with member 
clinics to guide implementation of policies and 
programs that benefit clinics and their target pop-
ulations, achieving the fourth and fifth program 
outcomes. Last, nearly of all the grant-supported 
initiative described in the individual case studies 
are or will result in meaningful communitywide 
change, such as a strengthened safety net that will 
facilitate adoption of national health care reform. 
The findings speak to the ability of consortia to 
branch out and be agents for systems change, cre-
ating lasting improvements to their local health 
care delivery systems. They also suggest contin-
ued growth in some key areas, namely strength-
ened clinic advocacy, developing expertise in new 
policy arenas, and partnering with allies within 
and outside the health care arena. The challenge 
is to leverage these gains and seek new opportu-
nities, such as implementing health care reform, 
as well as serving populations that are not being 
covered under traditional channels of health care 
insurance and health care.
The implications of the findings for funders and 
evaluators of advocacy and policy change are 
three-fold. First, systematically increasing and 
sustaining the organizational capacity to achieve 
a policy change is feasible, and attention needs 
to be paid to how this capacity is developed 
Systematically increasing and 
sustaining the organizational 
capacity to achieve a policy change 
is feasible, and attention needs 
to be paid to how this capacity is 
developed and sustained.
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and sustained. Creating a potent voice in the 
policymaking and political arenas benefits from 
directing funding to a designated policy director 
and planning for a two- to three-year period to 
achieve capacity expansion. Planning for sustain-
ability is also key, particularly when funders no 
longer provide the financial resources. Second, a 
multifaceted evaluation approach for examining 
organizations engaged in advocacy expands our 
understanding of factors that contribute to advo-
cacy success, including involvement in all facets 
of a policy or program initiative; maintenance of 
partnerships, particularly with member clinics; 
and technical expertise to launch and maintain 
an initiative. Third, process measures, such as 
“expanded advocacy capacity” and “educating 
policymakers,” have practical utility for grantees 
and funders, providing information for targeting 
resources, such as training in media advocacy and 
grassroots mobilization. These insights and les-
sons learned point to the importance of investing 
in advocacy capacity building, while also striving 
to achieve sustainability of these efforts over the 
long run.
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